Entering text into the input field will update the search result below

Ionis Pharma names Eugene Schneider as its clinical development chief

  • Ionis Pharmaceuticals (NASDAQ:IONS) promotes Eugene Schneider to EVP and chief clinical development officer.
  • Dr. Schneider joined Ionis in 2013 and has played a key role in more than 20 clinical trials conducted in the U.S. and globally. In this new role, Dr. Schneider will oversee clinical development of

Recommended For You

About IONS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
IONS--
Ionis Pharmaceuticals, Inc.